Avoro Capital Advisors LLC Diversified Active

Location: NEW YORK, NY

CIK: 0001633313 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $5,412,850 (100.0% shares, 0.0% debt)

Holdings (39)

APLS APELLIS PHARMACEUTICALS INC 12.8%
Value ($000) $691,538 Shares 10,125,000 Est. Cost $48.06 Unrealized +23.1%
UTHR UNITED THERAPEUTICS CORP 11.3%
Value ($000) $612,751 Shares 2,926,500 Est. Cost $133.73 Unrealized +67.2%
ARGX ARGENX SE 8.3%
Value ($000) $446,804 Shares 1,265,555 Est. Cost $136.82 Unrealized
MIRATI THERAPEUTICS INC 7.2%
Value ($000) $387,651 Shares 5,550,555 Est. Cost $53.82 Unrealized
SRPT SAREPTA THERAPEUTICS INC 6.5%
Value ($000) $350,965 Shares 3,175,000 Est. Cost $97.25 Unrealized +3.6%
HORIZON THERAPEUTICS PLC 5.9%
Value ($000) $317,186 Shares 5,125,000 Est. Cost $48.87 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 5.6%
Value ($000) $301,404 Shares 3,555,555 Est. Cost $83.64 Unrealized +6.5%
ASND ASCENDIS PHARMA 5.4%
Value ($000) $294,291 Shares 2,850,000 Est. Cost $124.63 Unrealized
FOLD AMICUS THERAPEUTICS INC 5.2%
Value ($000) $279,792 Shares 26,800,000 Est. Cost $10.43 Unrealized +6.8%
SEAGEN INC 4.7%
Value ($000) $255,188 Shares 1,865,000 Est. Cost $146.44 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 4.1%
Value ($000) $221,177 Shares 1,105,000 Est. Cost $153.75 Unrealized +24.1%
XENE XENON PHARMACEUTICALS INC 3.3%
Value ($000) $176,890 Shares 4,900,000 Est. Cost $16.29 Unrealized +120.7%
BCRX BIOCRYST PHARMACEUTICALS INC 2.1%
Value ($000) $114,030 Shares 9,050,000 Est. Cost $12.22 Unrealized +5.3%
IVERIC BIO INC 2.0%
Value ($000) $105,846 Shares 5,900,000 Est. Cost $6.39 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 1.8%
Value ($000) $99,760 Shares 1,535,000 Est. Cost $120.44 Unrealized -42.3%
KRYS KRYSTAL BIOTECH INC 1.6%
Value ($000) $88,868 Shares 1,275,000 Est. Cost $62.38 Unrealized +15.8%
IOVA IOVANCE BIOTHERAPEUTICS INC 1.6%
Value ($000) $86,412 Shares 9,020,000 Est. Cost $16.40 Unrealized -29.7%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value ($000) $53,400 Shares 2,222,222 Est. Cost $20.62 Unrealized +8.8%
MERSANA THERAPEUTICS INC 0.9%
Value ($000) $51,038 Shares 7,550,000 Est. Cost $21.34 Unrealized
KURA KURA ONCOLOGY INC 0.9%
Value ($000) $48,152 Shares 3,525,000 Est. Cost $23.38 Unrealized -34.0%
KYMR KYMERA THERAPEUTICS INC 0.9%
Value ($000) $47,224 Shares 2,169,230 Est. Cost $35.72 Unrealized -26.2%
WHWK AADI BIOSCIENCES INC 0.7%
Value ($000) $40,262 Shares 2,849,402 Est. Cost $24.27 Unrealized -45.9%
DSGN DESIGN THERAPEUTICS INC 0.7%
Value ($000) $37,156 Shares 2,222,222 Est. Cost $25.91 Unrealized -23.2%
PMVP PMV PHARMACEUTICALS INC 0.7%
Value ($000) $36,414 Shares 3,060,000 Est. Cost $25.09 Unrealized -42.4%
CYMABAY THERAPEUTICS INC 0.7%
Value ($000) $36,050 Shares 10,300,000 Est. Cost $6.26 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL INC 0.6%
Value ($000) $31,058 Shares 750,000 Est. Cost $64.00 Unrealized -19.7%
MNKD MANNKIND CORP 0.5%
Value ($000) $28,119 Shares 9,100,000 Est. Cost $3.56 Unrealized +6.0%
GLUE MONTE ROSA THERAPEUTICS INC 0.5%
Value ($000) $27,478 Shares 3,363,333 Est. Cost $20.20 Unrealized -54.5%
RNAM AVIDITY BIOSCIENCES INC 0.4%
Value ($000) $23,679 Shares 1,450,000 Est. Cost $24.02 Unrealized -20.4%
DICE THERAPEUTICS INC 0.4%
Value ($000) $21,801 Shares 1,075,000 Est. Cost $26.26 Unrealized
MARINUS PHARMACEUTICALS INC 0.4%
Value ($000) $20,948 Shares 3,150,000 Est. Cost $12.20 Unrealized
NUVL NUVALENT INC 0.4%
Value ($000) $20,402 Shares 1,049,471 Est. Cost $29.01 Unrealized -42.3%
AMLX AMYLYX PHARMACEUTICALS INC 0.3%
Value ($000) $18,298 Shares 650,000 Est. Cost $24.95 Unrealized 0.0%
FENC FENNEC PHARMACEUTICALS INC 0.2%
Value ($000) $9,720 Shares 1,200,000 Est. Cost $9.85 Unrealized -30.3%
RLAY RELAY THERAPEUTICS INC 0.2%
Value ($000) $8,948 Shares 400,000 Est. Cost $21.43 Unrealized +2.4%
AMARIN CORP PLC 0.1%
Value ($000) $6,540 Shares 6,000,000 Est. Cost $8.22 Unrealized
TNGX TANGO THERAPEUTICS INC 0.1%
Value ($000) $5,611 Shares 1,550,000 Est. Cost $11.99 Unrealized -64.4%
IOBT IO BIOTECH INC 0.1%
Value ($000) $5,571 Shares 2,055,883 Est. Cost $9.66 Unrealized -61.6%
BCAB BIOATLA INC 0.1%
Value ($000) $4,428 Shares 575,000 Est. Cost $6.55 Unrealized 0.0%